Invesco Ltd. (IVZ)
Financials22 articles
Price chart
Why is IVZ moving today?
-2.1%IVZ is -2.1% today, inside the ordinary range for a session (under 3%). No stories about it reached the feed in the last 24 hours.
What this does not prove. A story on the same day is evidence of timing, not of cause: it explains a move only if it accounts for the size and the direction, and most single-stock moves carry a sector or index component too. Nothing here is a forecast.
Source: Yahoo Finance - quote as of 2 days ago
Invesco Ltd. (IVZ) overview
Invesco is a global asset manager, known for the QQQ ETF.
IVZ is a member of the S&P 500. It sits in the Financials sector. That sector covers banks, insurers and capital-markets firms at the center of the economy.
Invesco Ltd. trades on the NYSE under the ticker symbol IVZ. The most recent market data puts the share price at about $28.20. That is down 2.08% on the session. At that price the company is worth roughly $12.45B.
Over the past 52 weeks, IVZ has traded between $20.67 and $33.66. IVZ also pays a dividend. It yields around 3.05% at the current price.
Key statistics
Source: Yahoo Finance - quote as of 2 days ago
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch IVZ
IVZ is one of the larger names in the Financials sector, so investors follow it closely. It tends to move with the rest of the sector. This page sums up each IVZ story as it breaks, and tags it bullish, bearish or neutral.
What moves IVZ
- Earnings. IVZ reports results four times a year. A surprise against the estimate tends to move the stock that day.
- Analyst calls. Upgrades, downgrades and new price targets change what the market expects from IVZ.
- Sector news. Financials stocks often move together, so a rival's news can move IVZ too.
Market Mood
Latest IVZ news
Paramount (PARA) Faces Mega Debt Sale Amid Higher Bond Yields
Paramount is engaging in a significant debt sale, a move indicating the impact of higher bond yields on corporate borrowing. Analysts from Invesco predict that the supply of corporate debt may decrease in the near term unless there are urgent borrowing needs. This environment of rising yields puts pressure on companies to manage their capital more strategically. For investors, understanding these dynamics can help shape expectations around corporate debt issuance and interest costs.
Read More: Paramount (PARA) Faces Mega Debt Sale Amid Higher Bond Yields
Invesco KBW Bank ETF (KBWB) Offers 1.9% Yield, Higher Return
The Invesco KBW Bank ETF (NASDAQ:KBWB) delivers a 1.9% yield with a concentration on 26 banking stocks, while the iShares U.S. Financials ETF (NYSEMKT:IYF) offers a lower yield of 1.4% across 141 holdings. The KBWB fund has a 0.35% expense ratio, which is slightly lower than IYF's 0.38%. In the past year, KBWB generated a higher total return compared to IYF, despite its increased volatility. This comparison is significant for investors weighing risk versus potential return in their financial sector investments.
Read More: Invesco KBW Bank ETF (KBWB) Offers 1.9% Yield, Higher Return
FHLC vs. PJP: Key Healthcare ETFs Show Divergence in Performance
The Fidelity MSCI Health Care Index ETF (FHLC) and Invesco Pharmaceuticals ETF (PJP) provide distinct options for investors, differing in fees, diversification, and returns. FHLC, launched in 2013, holds over 300 stocks and has paid $1.02 per share in dividends over the last year, making it more affordable with a higher yield compared to PJP, launched in 2005, which holds only 33 stocks and paid $1.06 per share in dividends. PJP has outperformed FHLC in both one- and five-year total returns, but its concentrated approach increases risk. Investors focusing on lower costs or income may find FHLC appealing, while those seeking high returns might prefer PJP.
Read More: FHLC vs. PJP: Key Healthcare ETFs Show Divergence in Performance
AMD Down 5% as 30-Year Treasury Yield Hits Highest Since 2007
On Tuesday, Advanced Micro Devices Inc. (NASDAQ: AMD) fell by 5%, while Broadcom Inc. (NASDAQ: AVGO) and Meta Platforms Inc. (NASDAQ: META) both decreased by around 3%, and NVIDIA Corp. (NASDAQ: NVDA) dropped 2%. This decline coincided with the 30-year Treasury yield reaching its highest level since 2007, which impacts future earnings valuations for tech companies. The Invesco QQQ Trust lost 1.4%, and the VanEck Semiconductor ETF dropped 4.3%. Market commentators highlight that rising yields could create a tighter borrowing environment, especially for AI investments. The current situation may affect ordinary investors by increasing costs associated with tech investments and potentially leading to lower valuations.
Read More: AMD Down 5% as 30-Year Treasury Yield Hits Highest Since 2007
QDTE's $13.33 Weekly Payout and 0.95% Expense Ratio Analyzed
The Roundhill N-100 0DTE Covered Call Strategy ETF (NYSEARCA:QDTE) has made 123 consecutive weekly distributions with a trailing 12-month payout of $13.33 per share. However, it carries a 0.95% expense ratio, which is significantly higher than the Invesco QQQ Trust (NASDAQ:QQQ) at 0.20%. This fee differential could cost investors over $2,000 per $10,000 invested over 20 years. Year-to-date through July 30, 2026, QQQ is up 11.27%, while QDTE's price is up 9.66% on an adjusted basis. This information is relevant for investors considering the trade-offs between income generation and potential upside.
Read More: QDTE's $13.33 Weekly Payout and 0.95% Expense Ratio Analyzed
XLV vs PBE: Comparing Two Healthcare ETFs for Investors
The State Street Health Care Select Sector SPDR ETF (XLV) has an expense ratio of 0.08% and offers a yield of 1.6%, while the Invesco Biotechnology & Genome ETF (PBE) has a 0.58% expense ratio and a yield of 1.7%. XLV includes 60 holdings like Eli Lilly & Co (NYSE:LLY) at 16.5% and Johnson & Johnson (NYSE:JNJ) at 10.6%. In contrast, PBE holds 30 companies, with Vertex Pharmaceuticals (NASDAQ:VRTX) at 5.2% and Biogen Inc (NASDAQ:BIIB) at 5.1%. This comparison helps investors weigh low-cost sector exposure versus targeted growth potential in biotechnology.
Read More: XLV vs PBE: Comparing Two Healthcare ETFs for Investors
QQQI Offers 14% Yield with AI Upside Preservation Strategy
The NEOS Nasdaq-100® High Income ETF (NASDAQ:QQQI) provides a yield of 14% using Section 1256 index options, balancing premium income with AI upside. Over the trailing year, the Invesco QQQ Trust (NASDAQ:QQQ) has returned 26%, influenced by major holdings like NVIDIA and Microsoft. In comparison, the JPMorgan Nasdaq Equity Premium Income ETF (NASDAQ:JEPQ) and Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ:GPIQ) implement different strategies for yield and exposure. These covered call ETFs are designed to offer investors attractive income without excessively capping growth potential, making them relevant for those interested in tech-driven markets.
Read More: QQQI Offers 14% Yield with AI Upside Preservation Strategy
Invesco QQQ Trust (QQQ) sees $24M Options Trade Highlights
The Invesco QQQ Trust (QQQ) experienced a notable $24 million options trade on Thursday, involving a three-part call spread aimed at an all-time high for the Nasdaq-100 index by the end of June. The main transaction included purchasing 28,000 calls with a 736 strike price, expiring July 31, along with a sale of 730/740-strike calls to reduce costs. With $1.6 billion in QQQ options traded that day, $944 million was tied to calls, indicating a mixed sentiment. This significant market activity suggests potential bullish trends that could influence future trading for both QQQ and overall market sentiment.
Read More: Invesco QQQ Trust (QQQ) sees $24M Options Trade Highlights
IHE vs PJP: Key ETF Metrics Include Expense Ratios and Dividends
The iShares U.S. Pharmaceuticals ETF (IHE) has an expense ratio of 0.38% and a dividend yield of 1.62%, while the Invesco Pharmaceuticals ETF (PJP) has a higher expense ratio of 0.57% and a dividend yield of 0.96%. IHE holds 56 positions, heavily concentrated in Eli Lilly (NYSE:LLY) at 24.2% and Johnson & Johnson (NYSE:JNJ) at 20.3%. In contrast, PJP features 29 companies with Eli Lilly at 5.4%. Investors' choice between IHE and PJP hinges on their comfort with company-specific risks within the pharmaceutical sector.
Read More: IHE vs PJP: Key ETF Metrics Include Expense Ratios and Dividends
QQQ vs. VOO: 19.9% vs. 9.5% Returns in 2023 Performance
In the first half of 2023, the Invesco QQQ ETF (QQQ) achieved a return of 19.9%, more than doubling the Vanguard S&P 500 ETF (VOO) return of 9.5%. Since its inception, QQQ's total return exceeds 1,580%. The tech concentration in QQQ, which comprises approximately 67% of its assets, contributes to its superior performance, while the S&P 500 has nearly 40% of its assets in tech. Both ETFs are susceptible to shifts in market trends and economic conditions, highlighting the need for careful investment alignment with individual objectives.
Read More: QQQ vs. VOO: 19.9% vs. 9.5% Returns in 2023 Performance
SPHD and DIVO ETFs Offer Reliable Monthly Income for Retirees
The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) provides a 4.5% yield, while the Amplify CWP Enhanced Dividend Income ETF (DIVO) offers a 6% yield. SPHD's expense ratio is 0.30%, and it has returned $2.33 per share over the last 12 months, translating to approximately $2,330 annually for a 1,000-share investment. The funds are designed to deliver monthly income while maintaining lower volatility compared to aggressive options. Together, SPHD and DIVO aim to provide dependable income for retirees amid market fluctuations.
Read More: SPHD and DIVO ETFs Offer Reliable Monthly Income for Retirees
SPY vs. QQQ: ETF Analysis for 2026 Investment Decisions
The State Street SPDR S&P 500 ETF Trust (SPY) has an expense ratio of 0.095% and a 1-year return of 25% as of June 19, 2026, while the Invesco QQQ (QQQ) charges 0.18% with a 40% return. SPY has about $765.3 billion in AUM and offers a 1% dividend yield compared to QQQ's 0.4%. Over five years, an investment in SPY grew to approximately $1,906, while QQQ’s $1,000 grew to about $2,173. The broader diversification of SPY includes 504 stocks, while QQQ is concentrated with only 102 stocks, impacting growth potential and risk levels.
Read More: SPY vs. QQQ: ETF Analysis for 2026 Investment Decisions
SP500 ETF Investors Face Risk with 39% Tech Exposure by 2027
The Vanguard S&P 500 ETF (VOO) currently allocates 39% of its assets to the technology sector, while the Vanguard Total Stock Market ETF (VTI) allocates 42%. The S&P 500 committee has indicated that SpaceX could account for 3%-4% of the index upon its inclusion in 2027, along with potential future IPOs like Anthropic and OpenAI. This growing tech exposure underscores the need for diversification as tech could represent half of the S&P 500 by the end of 2027. Investors may want to consider alternatives, such as the Invesco S&P 500 Equal Weight ETF (RSP), which redistributes sector weightings.
Read More: SP500 ETF Investors Face Risk with 39% Tech Exposure by 2027
S&P 500 Futures Rose 0.1% Ahead of Fed Decision on Rates
On Wednesday, S&P 500 futures increased by 0.1% while Nasdaq-100 futures rose by 0.5% as traders awaited the Federal Reserve's monetary policy decision. SpaceX shares rose by more than 1% premarket, following a 50% increase since its IPO at $135 last week. Additionally, the Invesco PHLX Semiconductor ETF (SOXQ) was up by 2%, with notable gains from ASML (up 4%) and Intel (up nearly 3%). The Fed is expected to maintain interest rates at 3.5% to 3.75%, marking a key point for market sentiment.
Read More: S&P 500 Futures Rose 0.1% Ahead of Fed Decision on Rates
TQQQ Grows $10K to $3.64M in 16 Years — Key Performance Insights
ProShares UltraPro QQQ (TQQQ) turned an initial investment of $10,000 into $3.64 million over 16 years, reflecting a cumulative total return of 36,309.63%. In contrast, the Invesco QQQ Trust (QQQ) returned approximately 1,500% in the same period, moving from about $44 to $702. Recent performance shows TQQQ experienced a 12% decline over five days, while QQQ slipped by 4%. TQQQ's substantial growth highlights the impact of a sustained tech rally and suppressed volatility since its inception on February 11, 2010.
Read More: TQQQ Grows $10K to $3.64M in 16 Years — Key Performance Insights
Senior Loan ETFs BKLN, SRLN Offer $35,000 Annual Income
A $500,000 position in senior loan ETFs like BKLN and SRLN generates $35,000 annually at a 7% yield. As the Federal Funds target rate approaches 4%, these floating-rate funds adjust upwards, potentially increasing income. Comparatively, a $1,000,000 dividend growth portfolio starting at a 3.5% yield could reach $70,000 in annual income by year 10. The Invesco Senior Loan ETF (BKLN) has $7.15 billion in net assets, offering diversification across over 200 issuers, while both BKLN and SRLN returned approximately 5% over the past year.
Read More: Senior Loan ETFs BKLN, SRLN Offer $35,000 Annual Income
Vanguard S&P 500 ETF (VOO) Holds $1.6 Trillion in Assets
The Vanguard S&P 500 ETF (VOO) has accumulated $1.6 trillion in total assets, making it a popular choice for investors seeking exposure to large-cap U.S. companies. The ETF features a low expense ratio of 0.03%. In contrast, major stocks like Nvidia (NVDA) and Apple (AAPL) now dominate the S&P 500, with Nvidia comprising nearly 8% and Apple about 6.5% of the index. This concentration risk drives some investors toward alternatives such as the Invesco Equal Weight S&P 500 ETF (RSP), which allocates approximately 0.2% to each of the 500 companies, mitigating potential losses from underperforming stocks.
Read More: Vanguard S&P 500 ETF (VOO) Holds $1.6 Trillion in Assets
Invesco Optimum Yield ETF (PDBC) Up 41% Amid Inflation
The Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC) has gained approximately 41% over the past year and 30% year-to-date, attributed to persistent inflation and high energy prices. WTI crude oil has reached the 99.6th percentile of its 12-month range, coinciding with CPI hitting its highest level in March 2026. PDBC holds around $6.5 billion in net assets, providing diversified exposure to various commodity futures. Its unique C-corporation structure generates 1099 forms, simplifying tax filings for taxable accounts, which is significant for investors managing inflation risks.
Read More: Invesco Optimum Yield ETF (PDBC) Up 41% Amid Inflation
XSHD Dividend Decline: 40% drop in monthly distributions noted
Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD) has seen a 40% decline in monthly distributions from early 2024, dropping from $0.09 to $0.05346 per share by March 2026. This decline highlights issues faced by its top holdings, which include Innovative Industrial Properties (3.5%), Cal-Maine Foods (3.3%), and Arbor Realty Trust (3%). The fund's yield stands at 5.42%, attracting income-focused investors, despite a significant underperformance relative to peer small-cap value ETFs, achieving only a 4.72% price return over five years compared to 22-41% by peers. The downturn in payouts poses concerns for dividends' reliability in the current market environment.
Read More: XSHD Dividend Decline: 40% drop in monthly distributions noted
S&P 500 Tech Stocks Risk: 33% of Index Value in 2026
As of April 2026, the S&P 500's (SNPINDEX: ^GSPC) value is increasingly dominated by tech stocks, with the 'Magnificent Seven'—including Nvidia, Apple (AAPL), and Microsoft (MSFT)—accounting for approximately 33% of the index. This represents a significant increase from about 12% ten years ago. As tech stocks are more vulnerable to volatility, S&P 500 index funds may experience heightened risk compared to a decade prior. Investors seeking reduced tech exposure may consider alternatives like the Invesco S&P 500 Equal Weight ETF (NYSEMKT: RSP), which offers a more balanced investment approach.
Read More: S&P 500 Tech Stocks Risk: 33% of Index Value in 2026
XAR ETF Price Target Suggests 24.4% Upside Amid Defense Developments
Eurasia Group's Firas Maksad indicated that President Donald Trump may be nearing a key decision regarding the conflict with Iran, with a target timeframe around mid-April. The arrival of additional U.S. military assets is expected during this period. Analysts have suggested potential strategies for investors to hedge against escalations in the conflict, pointing to defense ETFs such as Invesco Aerospace & Defense (PPA), iShares U.S. Aerospace & Defense (ITA), and SPDR S&P Aerospace & Defense (XAR). Notably, XAR has a price target of $324.76 per share, indicating a 24.4% upside potential for investors.
Read More: XAR ETF Price Target Suggests 24.4% Upside Amid Defense Developments
Invesco Reduces Management Fee on MSCI World ETF to 0.05%
Invesco has decreased the management fee for its MSCI World ETF from a previous rate to 0.05%. This reduction is aimed at enhancing the attractiveness of the fund, which tracks large- and mid-cap equities across 23 developed markets. Lower fees can impact investor returns positively, potentially leading to increased inflows. Such changes in management fees often influence investor decisions in a competitive ETF market.
Read More: Invesco Reduces Management Fee on MSCI World ETF to 0.05%More Financials stocks
Frequently asked questions
Is Invesco Ltd. in the S&P 500?
Yes. Invesco Ltd. trades as IVZ and is a member of the S&P 500. The index lists it in the Financials sector.
What sector is IVZ in?
IVZ sits in the Financials sector of the S&P 500.
Where can I find the latest IVZ news?
Right here. This page collects recent IVZ news and market analysis. Every story gets an AI summary and a bullish, bearish or neutral tag.
What is Invesco Ltd.'s stock price?
IVZ last traded at about $28.20. Prices move all through the session, so this is the latest quote rather than a live one.
What is Invesco Ltd.'s market cap?
IVZ is worth roughly $12.45B. Market cap is the share price times the number of shares outstanding.